Lenalidomide (Revlimid), bortezomib (Velcade) and dexamethasone for the treatment of secondary plasma cell leukemia. uri icon

Overview

publication date

  • June 27, 2014

Research

keywords

  • Antineoplastic Combined Chemotherapy Protocols
  • Leukemia, Plasma Cell
  • Neoplasms, Second Primary

Identity

Scopus Document Identifier

  • 84922368959

Digital Object Identifier (DOI)

  • 10.3109/10428194.2014.893304

PubMed ID

  • 24884320

Additional Document Info

volume

  • 56

issue

  • 1